HelixNano
Clinical-stage mRNA startup building next-generation mRNA technologies, vaccines and therapies to augment the immune system's power to fight disease. Tackling cancer with cancer vaccines targeting metastatic tumors, with an ongoing Phase 1 clinical trial for a COVID vaccine designed for immunocompromised patients.
- Founded
- Not disclosed
- Headquarters
- Boston, MA, USA; Cambridge, MA, USA
- Company size
- Not disclosed
- Products tracked
- 1
Products by HelixNano
Pricing for HelixNano
Contact sales
Contact HelixNano for current plans, volume pricing, and enterprise terms.
Trust profile
Security and compliance
GMP practices